Article
Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.
Annals of hematology - 1 Sept 2016
Pei Yu-Qing, Wu Yue, Wang Fei, Cui Wei
Abstract excerpt
The understanding of genetic basis for Philadelphia-negative myeloproliferative neoplasm (MPN) has got much progress in recent years. But the effect of CALR vs. JAK2V617F mutations on the clinical progression and prognosis of primary fibrosis (PMF) remains relatively obscure. In this meta-analysis, we searched Pubmed, Embase, and Web of Science databases for observational studies published until February 2016....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.